Hedge Fund - Iridian Asset Management

Iridian Asset Management, led by David Cohen and Harold Levy, disclosed 98 long positions in its latest 13F filing with the U.S.

David Cohen and Harold Levy, a duo of special situation investors with a focus on depressed stocks that go through significant changes, founded Iridian Asset Management in 1996.

Both Antares Pharma Inc (NASDAQ:ATRS) and Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) recently had their names attached to 13G forms, as two hedge funds raised their holdings in the companies.

In its latest 13F filing with the U.S.

David Cohen and Harold Levy of Iridian Asset Management have significantly increased their stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) according to a recent 13G form filed with the SEC.

Iridian Asset Management was founded in 1996 by David Cohen and Harold Levy who each have investment industry experience of more than 20 years.

David Cohen and Harold Levy are founders of Iridian Asset Management. Messrs.

David Cohen and Harold Levy’s Iridian Asset Management filed several 13G forms with the U.S. Securities and Exchange Commission on Thursday, disclosing an increase in numerous positions.

David Cohen and Harold Levy’s Iridian Asset Management revealed the sale of two major positions on Thursday. As disclosed in a 13G Form filed with the U.S.